GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 793 filers reported holding GLAXOSMITHKLINE PLC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $608,854,000 | -41.2% | 16,069 | -33.8% | 1.44% | +28.0% |
| Q3 2019 | $1,035,800,000 | +99977.3% | 24,269 | -6.2% | 1.12% | +3.7% |
| Q2 2019 | $1,035,000 | -16.0% | 25,865 | -12.3% | 1.08% | -2.1% |
| Q1 2019 | $1,232,000 | +8.9% | 29,476 | -0.4% | 1.11% | -0.4% |
| Q4 2018 | $1,131,000 | -43.4% | 29,600 | -40.5% | 1.11% | -22.2% |
| Q3 2018 | $1,998,000 | +67.1% | 49,752 | +67.5% | 1.43% | +101.4% |
| Q2 2018 | $1,196,000 | -99.9% | 29,694 | -11.0% | 0.71% | -2.6% |
| Q1 2018 | $1,304,234,000 | -83.3% | 33,382 | -84.9% | 0.73% | -79.6% |
| Q4 2017 | $7,819,361,000 | +253.2% | 220,450 | +304.3% | 3.57% | +267.6% |
| Q3 2017 | $2,213,918,000 | -15.5% | 54,530 | -10.3% | 0.97% | -1.6% |
| Q2 2017 | $2,620,876,000 | -36.7% | 60,781 | -38.1% | 0.99% | -22.8% |
| Q1 2017 | $4,138,172,000 | +73.3% | 98,154 | +77.3% | 1.28% | +26.6% |
| Q3 2016 | $2,387,806,000 | – | 55,363 | – | 1.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |